Register
Login:
Share:
Email Facebook Twitter


London South East Natural Resources Webcast


Syncona Share Chat (SYNC)



Share Price: 213.50Bid: 213.50Ask: 214.00Change: 0.00 (0.00%)No Movement on Syncona
Spread: 0.50Spread as %: 0.23%Open: 215.00High: 215.50Low: 212.50Yesterday’s Close: 213.50


Share Discussion for Syncona


Thread View

Please login or register to post a message on Share Chat.

Posts per page:


oldabutnowisa
Posts: 731
Off Topic
Opinion:No Opinion
Price:215.00
Pretty Chart
Tue 10:33
Wish more of mine looked like this.
 
Noise
Posts: 2,601
Off Topic
Opinion:No Opinion
Price:208.50
RE: More good news
3 May '18
I did think Valirx's VAL201 would be a potential superb complementary product for Axumin. Imagine controlling the PET imaging of prostate as well as a therapeutic anti-cancer agent with no side effects? (TBC in further trials anyway). Especially since Axumin may also work well in Breast cancer.
oldabutnowisa
Posts: 731
Off Topic
Opinion:No Opinion
Price:208.00
More good news
2 May '18
from Blue Earth today. One thing SYNC is falling behind on is adding to its newco portfolio. As far as I recall not added since the first flush when the theory was to add at least one a year. I would have thought with Welcome as a partner SYNC must have queue of exciting prospects. Lets be adding one then! Suspect the reason may be that it might mean dropping an existing duffer and they are reluctant to do that.
Noise
Posts: 2,601
Off Topic
Opinion:No Opinion
Price:205.50
RE: Talking to myself again
20 Mar '18
Hello there, yes I'm still around and keep my holdings in SYNC. It seems the SP has plateaued slightly of late, however Blue Earth and Nightstar seem to be plodding forward at a rate of knots, so I suspect this is partly because the progress was already priced into the SP.

Very happy with Valirx's technical progress and patent news as well, highly enjoy the technical potential as well, SCLP seem to be doing OK too so there's a reasonable amount of funky UK Biotech going on right now (I am not fully researched nor invested in SCLP, but from a laymans overview it appears like a nice technology).

Nightstar (part of the SYNC portfolio) is actively out there curing (or preventing blindness) in a bunch of clinical trials, I am not sure whether there is any competition in the states, but the progress seems good from what has been publicly reported. It's now treating Choroideremia and X-linked retinitis pigmentosa, with Best Vitelliform macular dystrophy and Stargardt disease in the pipeline.

The general concept of using an engineering virus to correct DNA mutations and provide functional copies of key proteins is good. But it does require surgery (i.e. it's not in pill form) so I would imagine the training curve will be steep for the rollout.
oldabutnowisa
Posts: 731
Off Topic
Opinion:Strong Buy
Price:207.00
Pick 'n' Mix
18 Mar '18
It feels like time for SYNC to be adding to the seven cos in their youngbloods group. Four are now comparatively mature and the money could come from small sales of ones which have been floated. I am sure they already have their eye on a few. RNS not expected for a few months yet but this is the type on investment which can always surprise and delight.
oldabutnowisa
Posts: 731
Off Topic
Opinion:Strong Buy
Price:206.50
Talking to myself again
16 Mar '18
Is Noise still out there? This still has much further to go. I wish I had invested more
oldabutnowisa
Posts: 731
Off Topic
Opinion:Strong Buy
Price:191.00
Sunday Times 1/10/17 Insidethe City
2 Oct '17
Re my post the other day, all we need now is lots more good news!
oldabutnowisa
Posts: 731
Off Topic
Opinion:Strong Buy
Price:189.00
HEADLINES!
1 Oct '17
Well it's nice to get something right! Latest on the U.S new issue has sparked a big rise and some interest. It is too much to expect in this field that all its ventures will turn to platinum - bound to be failures and setbacks but the Welcome Trust portfolio has the gems in it as I suspected. The questions now are: 1) What new prospects will be added over time and will they be as good? 2) how high can the SP go before it is realistic to think of taking some profit? I can't answer the first but I can see the price doubling within a year or so and that might be a good point to cash some in.
oldabutnowisa
Posts: 731
Off Topic
Opinion:Strong Buy
Price:174.50
Nice Positive Chart in weak market
19 Jul '17
Doing well on my little investment. Seems those in the know think (like me) the portfolio cos - or at least a few more of them - could win big and SYNC's holdings could reflect this.
oldabutnowisa
Posts: 731
Off Topic
Opinion:Buy
Price:160.00
Weekend write ups?
27 May '17
Blue Earth is gonna gush over next two years and someone is bound to tip this because it really isn't in the price.
The portfolio has many other cos of interest and it is reasonable to trust Welcome to have at least one other winner in there.




Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk






Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.